Status:
WITHDRAWN
Autologous Regenerative Technology (ART) For Wound Healing
Lead Sponsor:
Stanford University
Conditions:
Chronic Wounds
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to provide a more effective method of harvesting skin with minimal or no pain, heal more rapidly with little scarring in an outpatient setting with the use of only local an...
Detailed Description
Skin wounds sometimes are difficult to heal by primary closure and often require tissue substitution by autologous grafting requiring harvesting of donor skin. The latter may cause morbidities such as...
Eligibility Criteria
Inclusion
- Any age ranging 18-90, any gender or ethnic background is a candidate.
- Subjects with chronic wounds that have been present for at least 4 weeks
Exclusion
- Pregnant women.
- Adults unable to consent.
- Prisoners.
- Subjects requiring concurrent systemic antimicrobials during the study period for any infection.
- Subjects with leg lesions and clinically significant and unreconstructed peripheral arterial disease.
- Subjects who are receiving immunosuppressive agents, radiation therapy, or cytotoxic agents.
- Subjects who require treatment for a primary or metastatic malignancy (other than squamous or basal cell carcinoma of the skin).
- Subjects with other conditions considered by the investigator to be reasons for disqualification that may jeopardize subject safety or interfere with the objectives of the trial (e.g., acute illness or exacerbation of chronic illness, lack of motivation, history of poor compliance).
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03368534
Start Date
December 1 2018
End Date
December 1 2022
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Advanced Wound Care Center
Redwood City, California, United States, 94063